Based on WHO | Can mesothelioma cause dizziness, and what mechanisms or complications of the disease might lead to this symptom?

Overview

Dizziness is not a classic, primary symptom of mesothelioma, but it can occur indirectly through several disease‑related mechanisms or treatment‑related complications. These include low red blood cell counts (anemia), fluid buildup around the lungs (pleural effusion) leading to poor oxygenation, pain and local tumor effects on the chest, blood pressure changes, kidney issues, and rarely neurological complications or metastasis. ^[1] Dizziness may also arise from side effects of common mesothelioma chemotherapies such as cisplatin, pemetrexed, and bevacizumab, which can cause high blood pressure, reversible posterior leukoencephalopathy syndrome (RPLS), dehydration, and anemia. ^{[2] [3] [4]} Recognizing the underlying cause is important because management strategies differ depending on whether the source is tumor‑related, treatment‑related, or due to general health changes. ^[5]

---

How mesothelioma itself can contribute to dizziness

• Pleural effusion and breathlessness: Pleural mesothelioma often causes a buildup of fluid around the lungs (pleural effusion), which compresses lung tissue and makes breathing harder; reduced oxygen levels and shortness of breath can make someone feel light‑headed or dizzy. ^[6] As many as 30% of people present with breathlessness from effusion, which can indirectly lead to dizziness through hypoxia and poor ventilation. ^[1]

• Local tumor pressure and pain: As tumors spread within the chest, they press on nearby structures, causing trouble breathing and chest pain; the combination of pain, shallow breathing, and reduced activity tolerance can trigger dizziness, especially during exertion. ^[6] Clinical deterioration in mesothelioma is primarily due to local spread in the chest, which can aggravate respiratory symptoms and thereby contribute to light‑headedness. ^[5]

• Anemia (low red blood cells): Mesothelioma and its treatments can be associated with anemia, which reduces oxygen delivery to the brain and can cause dizziness, fatigue, and pallor; anemia may develop over weeks to months. ^[7] Anemia can require monitoring and sometimes transfusion, and it is a recognized late effect in common mesothelioma chemotherapy regimens. ^[4]

• Paraneoplastic hematologic changes: Mesothelioma can be associated with blood count abnormalities such as thrombocytosis (high platelets), reflecting systemic inflammation; while thrombocytosis itself is not a direct cause of dizziness, it signals an active disease state that may coincide with anemia or increased clotting risk, both of which can contribute to light‑headedness or neurologic symptoms if complications occur. ^[8] Thrombocytosis appears disproportionately common in malignant pleural mesothelioma compared with several lung cancer types, underscoring the disease’s systemic effects. ^[9]

---

Treatment‑related causes of dizziness

• High blood pressure (hypertension): Bevacizumab, frequently combined with cisplatin and pemetrexed, can raise blood pressure; severe hypertension can cause headaches, shortness of breath, and dizziness, requiring prompt evaluation and blood pressure monitoring during therapy. ^[2] High blood pressure related to treatment should be managed urgently if symptoms such as severe headaches, vision changes, or dizziness occur. ^[3]

• Reversible posterior leukoencephalopathy syndrome (RPLS): Bevacizumab can rarely cause RPLS, a neurological condition marked by dizziness, confusion, visual changes, trouble speaking, severe headache, seizures, and imbalance; immediate medical attention is necessary if these symptoms emerge. ^[3] This syndrome is reversible with timely recognition and treatment, but delays can be dangerous. ^[4]

• Chemotherapy‑induced anemia and fatigue: Cisplatin and pemetrexed regimens commonly lead to late‑onset anemia, which may present with dizziness, light‑headedness, and pronounced fatigue; monitoring blood counts helps guide interventions such as transfusion. ^[7] The same combination with bevacizumab also lists anemia as a late effect, consistent with dizziness symptoms. ^[4]

• Dehydration and electrolyte loss: Treatment‑related nausea or diarrhea can cause dehydration, lowering blood pressure and provoking dizziness or faintness; medical teams advise urgent care if diarrhea is uncontrolled and accompanied by feeling dizzy or light‑headed. ^[10] Adequate hydration and antidiarrheal management can reduce these risks during chemotherapy courses. ^[10]

• Kidney changes with cisplatin: Cisplatin can affect kidney function, which may lead to electrolyte disturbances contributing to dizziness; routine blood and urine tests track renal function during therapy. ^[3] Early detection of kidney changes enables dose adjustments and supportive care to prevent symptomatic instability. ^[3]

---

Less common neurological contributors

• Direct neurological involvement: While mesothelioma primarily causes local chest complications, severe systemic illness or rare central nervous system events could contribute to dizziness; clinicians focus on the predominant pattern of local spread rather than frequent brain metastasis, but atypical neurological symptoms warrant evaluation. ^[5] In such scenarios, imaging and neurological assessment help rule out less common causes. ^[1]

---

Practical signs that warrant urgent care

• Red‑flag symptoms with dizziness: Dizziness with severe headache, blurred vision, difficulty speaking, shortness of breath, unexplained falls, confusion, or seizures suggests potentially serious complications such as hypertensive crisis or RPLS related to therapy; prompt medical assessment is recommended. ^[3] Any chest pain with breathlessness or rapid worsening of symptoms during mesothelioma treatment should trigger immediate attention. ^[4]

---

What to monitor and discuss with your care team

• Respiratory symptoms: New or worsening shortness of breath, chest pain, or suspected pleural effusion should be investigated, as drainage and supportive measures can reduce light‑headedness due to poor oxygenation. ^[6] Effusion management may significantly improve breathing comfort and reduce dizzy spells during daily activities. ^[1]

• Blood counts and hydration: Regular checks for anemia and maintaining hydration can help prevent dizziness during chemotherapy; report pallor, fatigue, or light‑headedness, as these may indicate low red blood cells or dehydration. ^{[7] [10]} Treatment plans often include proactive lab monitoring and supportive care to minimize these risks. ^[4]

• Blood pressure: Home blood pressure monitoring during regimens that include bevacizumab can catch elevations early; persistent or severe elevations, especially with neurological symptoms, need immediate care. ^[2] Early intervention can prevent complications such as dizziness from hypertensive episodes or RPLS. ^[3]

---

Summary

Dizziness in mesothelioma is typically an indirect symptom arising from respiratory compromise (pleural effusion and breathlessness), anemia, treatment‑related blood pressure changes, dehydration, kidney effects, or rarely neurological complications like RPLS. ^{[6] [1]} Recognizing accompanying signs such as shortness of breath, chest pain, severe headache, visual changes, or confusion helps pinpoint urgent situations versus manageable side effects, guiding timely evaluation and tailored management. ^{[3] [4]}